You are invited to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2013 at Le Méridien Etoile in Paris, France, on Oct. 29th from 15:00 to 19:00.
This meeting is held before the 44th Union World Conference on Lung Health (The Union). During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, review WGND 2013 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.
The agenda for the meeting is:
| WGND Updates | ||
|
15:00-15:05 |
Welcome | Melvin Spigelman, Co-chair |
|
15:05-15:10 |
Update from Stop TB Partnership | Lucica Ditiu |
|
15:10-15:25 |
WGND Activities Update | Cherise Scott |
|
15:25-15:40 |
TB Drug Development Year-in-Review | Barbara Laughon |
| Clinical Development of TB Drugs | ||
|
15:40-15:55 |
Janssen Pharmaceutical, Inc. | Chrispin Kambili |
|
15:55-16:10 |
Otsuka Pharmaceutical | Jeff Hafkin |
|
16:10-16:25 |
Pan-African Consortium for Evaluation of Anti-TB Antibiotics (PanACEA) | Michael Hoelscher |
|
16:25-16:40 |
Sequella, Inc. | Carol Nacy |
|
16:40-16:55 |
Global Alliance for TB Drug Development (TB Alliance) | Christo van Niekerk |
|
16:55-17:10 |
Coffee Break | |
|
17:10-17:25 |
Tuberculosis Trials Consortium (TBTC) | Neil Schluger |
|
17:25-17:40 |
AIDS Clinical Trials Group (ACTG) | Gavin Churchyard |
|
17:40-17:55 |
INTERTB/St. George’s University of London | Amina Jindani |
| Discovery and Preclinical Development | ||
|
17:55-18:10 |
Q203 (Qurient) | Kiyean Nam |
|
18:10-18:25 |
Preclinical Assessment of Novel TB Regimens | Dan Everitt |
|
18:25-18:40 |
Update on Preclinical Research | Jacques Grosset |
|
18:40-18:55 |
GSK Tres Cantos Open Innovation Lab | David Barros |
| Closing | ||
|
18:55-19:00 |
Closing and Announcements | Barbara Laughon, Co-chair |
Please register by sending an e-mail reply to wgnd@newtbdrugs.org.
If you have any questions, please feel free to contact Cherise Scott, WGND Secretariat.
Explore. Learn. Join the Conversation at www.newtbdrugs.org.